Paydirt
HJ
Insider

Heidy King-Jones

See Remarks

Heidy King-Jones (See Remarks) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Spyre Therapeutics, Inc. (SYRE). The largest single filing was $2.4M of SYRE (27,599 sh across 3 lots, as filed), executed Sep 1.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.4M
shares × price, as filed
Last traded
Sep 1
Filed Sep 3

Median ADV $134.1M across their filed names

Open performance→
Volume by month
$2.4M$1.2M$0Oct 2024Apr 2025Oct 2025Apr 2026Sep 2026 · sells $2.4M
Buys $0 Sells $2.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
SYRE Spyre Therapeutics, Inc. SYRE · 0 buys · 1 sell 1 filing
Recent filings
SYRESALE Spyre Therapeutics, Inc. View filing → $2.4M
27,599 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 9:34 PM ET